bioRxiv / medRxiv
open access
CC BY 4.0
In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Virus-immune signatures reveal distinct clinical phenotypes and predict prognosis in patients with Kaposi's sarcoma.#275521
- Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)#896412
- A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS#1114414
- Effect of nipocalimab on IgG responses to vaccinations and viral infections in patients with IgG autoantibody–mediated diseases: post hoc analyses of 3 randomized, placebo-controlled trials#236473
- HIV Drug Resistance Testing by High-Multiplex “Wide” Sequencing on the MiSeq Instrument#1065581
Record · ID 424128
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive